Therapeutic Potential of Prodrugs Towards Targeted Drug Delivery.

Q2 Pharmacology, Toxicology and Pharmaceutics
Open Medicinal Chemistry Journal Pub Date : 2018-10-23 eCollection Date: 2018-01-01 DOI:10.2174/1874104501812010111
Abhinav P Mishra, Suresh Chandra, Ruchi Tiwari, Ashish Srivastava, Gaurav Tiwari
{"title":"Therapeutic Potential of Prodrugs Towards Targeted Drug Delivery.","authors":"Abhinav P Mishra,&nbsp;Suresh Chandra,&nbsp;Ruchi Tiwari,&nbsp;Ashish Srivastava,&nbsp;Gaurav Tiwari","doi":"10.2174/1874104501812010111","DOIUrl":null,"url":null,"abstract":"<p><p>In designing of Prodrugs, targeting can be achieved in two ways: site-specified drug delivery and site-specific drug bioactivation. Prodrugs can be designed to target specific enzymes or carriers by considering enzyme-substrate specificity or carrier-substrate specificity in order to overcome various undesirable drug properties. There are certain techniques which are used for tumor targeting such as Antibody Directed Enzyme Prodrug Therapy [ADEPT] Gene-Directed Enzyme Prodrug Therapy [GDEPT], Virus Directed Enzyme Prodrug Therapy [VDEPT] and Gene Prodrug Activation Therapy [GPAT]. Our review focuses on the Prodrugs used in site-specific drug delivery system specially on tumor targeting.</p>","PeriodicalId":39133,"journal":{"name":"Open Medicinal Chemistry Journal","volume":"12 ","pages":"111-123"},"PeriodicalIF":0.0000,"publicationDate":"2018-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1874104501812010111","citationCount":"27","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Medicinal Chemistry Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874104501812010111","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 27

Abstract

In designing of Prodrugs, targeting can be achieved in two ways: site-specified drug delivery and site-specific drug bioactivation. Prodrugs can be designed to target specific enzymes or carriers by considering enzyme-substrate specificity or carrier-substrate specificity in order to overcome various undesirable drug properties. There are certain techniques which are used for tumor targeting such as Antibody Directed Enzyme Prodrug Therapy [ADEPT] Gene-Directed Enzyme Prodrug Therapy [GDEPT], Virus Directed Enzyme Prodrug Therapy [VDEPT] and Gene Prodrug Activation Therapy [GPAT]. Our review focuses on the Prodrugs used in site-specific drug delivery system specially on tumor targeting.

Abstract Image

Abstract Image

Abstract Image

前药靶向给药的治疗潜力。
在Prodrugs的设计中,靶向可以通过两种方式实现:定点给药和定点药物生物活化。通过考虑酶-底物特异性或载体-底物特异性,可以设计针对特定酶或载体的前药,以克服各种不良药物性质。目前用于肿瘤靶向治疗的技术有抗体定向酶前药物治疗(Antibody Directed Enzyme Prodrug Therapy, ADEPT)、基因定向酶前药物治疗(Gene-Directed Enzyme Prodrug Therapy, GDEPT)、病毒定向酶前药物治疗(Virus -Directed Enzyme Prodrug Therapy, VDEPT)和基因前药物激活治疗(Gene Prodrug Activation Therapy, GPAT)。本文综述了前药在肿瘤靶向给药系统中的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Open Medicinal Chemistry Journal
Open Medicinal Chemistry Journal Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
4.40
自引率
0.00%
发文量
4
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信